INTRODUCTION
Few effective medical treatment options are available for adrenocortical carcinoma (ACC). Intensive efforts are going on for exploring novel pathways and treatment targets. In our previous functional genomics study, retinoid signaling via the retinoid X receptor (RXR) was identified as a major pathogenic pathway in ACC and we have demonstrated the in vitro activity of 9-cis retinoic acid (9-cisRA) acting via the RXR on NCI-H295R cells. In this present study we have investigated the antitumoral effects of 9-cisRA and mitotane on ACC in vivo in a large-scale xenograft model. Endocrine Tumours
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